Jenkintown, PA, United States of America

Mark Hsieh

USPTO Granted Patents = 6 


Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 151(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2006)
  • San Francisco, CA (US) (2010)
  • Jenkintown, PA (US) (2008 - 2014)

Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations of Mark Hsieh in PCSK9 Antagonists

Introduction

Mark Hsieh is a notable inventor based in Jenkintown, PA, who has made significant contributions to the field of biochemistry, particularly in the development of PCSK9 antagonists. With a total of six patents to his name, Hsieh's work focuses on innovative solutions for conditions associated with PCSK9 activity.

Latest Patents

Among his latest patents are the AX132 and AX1 PCSK9 antagonists. These inventions disclose antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9), which are effective in inhibiting PCSK9 function. The disclosed antagonists present desirable options for treating conditions linked to PCSK9 activity. Additionally, the patents include nucleic acids encoding these antagonists, vectors, host cells, and compositions comprising the antagonists. Methods for creating PCSK9-specific antagonists and their applications for inhibiting or antagonizing PCSK9 function are also important aspects of these disclosures.

Career Highlights

Mark Hsieh has worked with prominent companies in the pharmaceutical industry, including Abmaxis, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative biopharmaceutical solutions.

Collaborations

Throughout his career, Hsieh has collaborated with notable colleagues such as Pingyu Zhong and Yan Li. These partnerships have likely enhanced his research and development efforts in the field of PCSK9 antagonists.

Conclusion

Mark Hsieh's contributions to the development of PCSK9 antagonists represent significant advancements in the treatment of related health conditions. His innovative work continues to impact the field of biochemistry and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…